Advisory Council on the Misuse of Drugs
E96679
The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Advisory Council on the Misuse of Drugs canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T826608 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Advisory Council on the Misuse of Drugs Context triple: [UK Home Office, oversees, Advisory Council on the Misuse of Drugs]
-
A.
Inter-American Drug Abuse Control Commission
The Inter-American Drug Abuse Control Commission is a specialized body of the Organization of American States that coordinates regional policies and programs to prevent and combat drug abuse and illicit trafficking in the Americas.
-
B.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
C.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
Drug and Alcohol Clearinghouse
The Drug and Alcohol Clearinghouse is a U.S. national database that tracks commercial drivers’ drug and alcohol program violations to enhance roadway safety and ensure compliance with federal regulations.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Advisory Council on the Misuse of Drugs Target entity description: The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
-
A.
Inter-American Drug Abuse Control Commission
The Inter-American Drug Abuse Control Commission is a specialized body of the Organization of American States that coordinates regional policies and programs to prevent and combat drug abuse and illicit trafficking in the Americas.
-
B.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
C.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
Drug and Alcohol Clearinghouse
The Drug and Alcohol Clearinghouse is a U.S. national database that tracks commercial drivers’ drug and alcohol program violations to enhance roadway safety and ensure compliance with federal regulations.
- F. None of above. chosen
Statements (51)
| Predicate | Object |
|---|---|
| instanceOf |
advisory body
ⓘ
expert committee ⓘ government advisory council ⓘ |
| advises |
Home Secretary
ⓘ
UK government ⓘ
surface form:
UK Government
|
| appliesToJurisdiction | United Kingdom ⓘ |
| composition |
experts from chemistry
ⓘ
experts from law enforcement ⓘ experts from medicine ⓘ experts from pharmacology ⓘ experts from public health ⓘ experts from social sciences ⓘ lay members ⓘ |
| coreFunction |
advise on classification of controlled drugs
ⓘ
advise on new psychoactive substances ⓘ assess harms of drugs ⓘ produce reports and recommendations on specific substances ⓘ provide evidence-based advice on drug policy ⓘ review scheduling of substances under the Misuse of Drugs Regulations ⓘ |
| country | United Kingdom ⓘ |
| establishedBy | Misuse of Drugs Act 1971 ⓘ |
| field |
addiction
ⓘ
drug control law ⓘ drug policy ⓘ epidemiology ⓘ pharmacology ⓘ public health ⓘ social policy ⓘ substance misuse ⓘ toxicology ⓘ |
| headOfGovernmentAdvised | Prime Minister of the United Kingdom ⓘ |
| inception | 1971 ⓘ |
| independence | statutory independent advisory body ⓘ |
| isPartOf | UK drugs advisory system ⓘ |
| jurisdiction | United Kingdom ⓘ |
| languageOfWork | English ⓘ |
| legalBasis | Misuse of Drugs Act 1971 ⓘ |
| legalMandate |
advise on dealing with the social problems connected with drug misuse
ⓘ
advise on measures for preventing the misuse of such drugs ⓘ advise on the control of dangerous or otherwise harmful drugs ⓘ keep under review the situation in the United Kingdom with respect to drugs which are being or appear to be misused ⓘ |
| locatedIn |
London, England
ⓘ
surface form:
London
|
| parentOrganization | Home Office ⓘ |
| reportsTo | Home Secretary ⓘ |
| scope | United Kingdom-wide ⓘ |
| shortName | ACMD ⓘ |
| topicOf |
drug classification system in the United Kingdom
ⓘ
policy debates on MDMA classification ⓘ policy debates on cannabis classification ⓘ policy debates on new psychoactive substances ⓘ |
| website | https://www.gov.uk/government/organisations/advisory-council-on-the-misuse-of-drugs ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Advisory Council on the Misuse of Drugs Description of subject: The Advisory Council on the Misuse of Drugs is an independent expert body in the United Kingdom that advises the government on drug-related issues, including classification, harms, and policy.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
https://www.gov.uk/government/organisations/home-office
→
oversees
→
Advisory Council on the Misuse of Drugs
ⓘ
subject surface form:
UK Home Office